Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

4D Molecular Therapeutics (FDMT) Receivables - Net (2019 - 2021)

4D Molecular Therapeutics (FDMT) has disclosed Receivables - Net for 3 consecutive years, with $47000.0 as the latest value for Q4 2021.

  • Quarterly Receivables - Net fell 96.84% to $47000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $47000.0 through Dec 2021, down 96.84% year-over-year, with the annual reading at $47000.0 for FY2021, 96.84% down from the prior year.
  • Receivables - Net for Q4 2021 was $47000.0 at 4D Molecular Therapeutics, down from $791000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $1.5 million in Q4 2020, with the low at $47000.0 in Q4 2021.
  • Average Receivables - Net over 3 years is $825500.0, with a median of $884500.0 recorded in 2019.
  • The sharpest move saw Receivables - Net skyrocketed 51.94% in 2020, then tumbled 96.84% in 2021.
  • Over 3 years, Receivables - Net stood at $978000.0 in 2019, then surged by 51.94% to $1.5 million in 2020, then crashed by 96.84% to $47000.0 in 2021.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $47000.0, $791000.0, and $1.5 million for Q4 2021, Q3 2021, and Q4 2020 respectively.